Mini-BEAM polychemotherapy plus G-CSF is superior to Cyclophosphamide alone plus G-CSF priming for peripheral blood stem cell collection for autologous stem cell transplantation in patients with malignant lymphomas

被引:0
作者
Minigo, H
Planinc-Peraica, A
Kolonic, SO
Kristo, DR
Turk, N
Baric-Besis, K
Maglov, C
Strauss-Patko, M
Siftar, Z
Kardum, M
Kardum-Skelin, I
Vrhovac, R
Kusec, R
Japec, V
Jaksic, O
Jaksic, B
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S75 / S76
页数:2
相关论文
共 50 条
  • [31] G-CSF after autologous hemopoietic stem cell transplantation in malignant lymphoma
    Deliliers, GL
    Tagliaferri, E
    Annaloro, C
    Della Volpe, A
    Soligo, D
    Pozzoli, E
    Marconi, M
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1998, 56 (01): : 33 - 42
  • [32] A prospective comparison of cytokines alone for peripheral blood progenitor cell collection in patients with advanced gynaecological malignancies: G-CSF versus G-CSF plus EPO
    Perillo, A
    Ferrandina, G
    Pierelli, L
    Rutella, S
    Bonanno, G
    Gallottal, V
    Paglia, A
    Mariotti, A
    Mancuso, S
    Scambia, G
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 132 - 132
  • [33] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    S Afifi
    N G Adel
    S Devlin
    E Duck
    J Vanak
    H Landau
    D J Chung
    N Lendvai
    A Lesokhin
    N Korde
    L Reich
    O Landgren
    S Giralt
    H Hassoun
    Bone Marrow Transplantation, 2016, 51 : 546 - 552
  • [34] A Retrospective Single Center Comparison of Cyclophosphamide Plus G-CSF Versus G-CSF Alone for Peripheral Blood Stem Cell (PBSC) Mobilisation Following First Line Therapy in Patients with Multiple Myeloma
    Whitmill, Richard S.
    Lewis, David J.
    Sutton, David John
    Khawaja, Jahanzeb
    Mayer, Georgina
    Paneesha, Shankaranarayana
    Nikolousis, Emmanouil
    Kishore, Bhuvan
    BLOOD, 2015, 126 (23)
  • [35] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    Afifi, S.
    Adel, N. G.
    Devlin, S.
    Duck, E.
    Vanak, J.
    Landau, H.
    Chung, D. J.
    Lendvai, N.
    Lesokhin, A.
    Korde, N.
    Reich, L.
    Landgren, O.
    Giralt, S.
    Hassoun, H.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 546 - 552
  • [36] Failure of adequate mobilization of peripheral blood progenitor cell (PBPC) with chemotherapy and G-CSF:: G-CSF alone is superior to chemotherapy plus G-CSF for 2nd mobilization.
    Fraipont, V
    Sautois, B
    Baudoux, E
    Pereira, M
    Fassotte, MF
    Jerusalem, G
    Hermanne, JP
    Longrée, L
    Schaaf-Lafontaine, N
    Sondag, D
    Fillet, G
    Beguin, Y
    BLOOD, 1998, 92 (10) : 268A - 268A
  • [37] COMPARISON OF PERIPHERAL BLOOD STEM CELL (PBSC) MOBILIZATION WITH G-CSF ALONE VS G-CSF WITH CYCLOPHOSPHAMIDE POST VCD INDUCTION IN MULTIPLE MYELOMA
    Chua, C. C.
    Lim, H. Y.
    Chai, K. L.
    Ong, J.
    Sim, S.
    Dickinson, M.
    Campbell, P.
    Hempton, J.
    King, H.
    Dowsing, C.
    Bergin, K.
    Muir, S.
    Gibbs, S.
    Grigg, A.
    HAEMATOLOGICA, 2016, 101 : 541 - 542
  • [38] Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
    Nazha, Aziz
    Cook, Rachel
    Vogl, Dan T.
    Mangan, Patricia A.
    Hummel, Kimberly
    Cunningham, Kathleen
    Luger, Selina
    Porter, David
    Schuster, Stephen J.
    O'Doherty, Una
    Sell, Mary
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 844 - 844
  • [39] An analysis of the optimal timing of peripheral blood stem cell harvesting following priming with cyclophosphamide and G-CSF
    Hill, Q. A.
    Buxton, D.
    Pearce, R.
    Gesinde, M. O.
    Smith, G. M.
    Cook, G.
    BONE MARROW TRANSPLANTATION, 2007, 40 (10) : 925 - 930
  • [40] An analysis of the optimal timing of peripheral blood stem cell harvesting following priming with cyclophosphamide and G-CSF
    Q A Hill
    D Buxton
    R Pearce
    M O Gesinde
    G M Smith
    G Cook
    Bone Marrow Transplantation, 2007, 40 : 925 - 930